|
ISMRM Scientific Workshop:
Improving Cancer Treatment with Advanced MR
Chaminade Conference Center, Santa Cruz, CA, USA
19-22 September 2010
|
|
Program |
|
| |
Sunday, 19 September
|
| |
|
|
16:00-18:00
|
Registration |
| |
|
|
18:30-21:00 |
Opening
Reception & Dinner |
| |
|
| |
Monday, 20 September
|
| |
|
|
07:00-17:30 |
Registration |
|
07:30-08:30 |
Breakfast |
|
08:30 |
Welcome |
| |
|
|
08:45 |
Session I:
Cancer Treatment Strategies, Chairs: Patrick Bolan, Ph.D. & Arend Heerschap, Ph.D.
|
|
08:45
|
MR Imaging & Improving the Management of Clinically Localized Prostate Cancer
Mack Roach, III, M.D., F.A.C.R.
University of California, San Francisco
San Francisco, CA, USA |
|
|
|
|
09:15 |
Changing Role
of Imaging for the Brain Tumor Patient
- permission
withheld
Susan M. Chang, M.D.
University of California, San Francisco
San Francisco, CA, USA |
|
|
|
|
09:45 |
Proffered Papers |
| |
|
| |
|
|
10:30 |
Coffee Break |
| |
|
|
11:00
|
Session II: MR
in Drug Research, Chair: Patricia E. Cole, M.D., Ph.D. |
|
11:00
|
MR Imaging of
Cancer Mechanisms: Examples from Glioblastoma
A. Gregory Sorensen, M.D.
Harvard Medical School
Charlestown, MA, USA |
| |
|
|
11:30
|
Therapeutic
Targets & Biomarkers In Choline Phospholipid Metabolism of
Cancer
Kristine Glunde, Ph.D.
Johns Hopkins School of Medicine
Baltimore, MD, USA |
| |
|
|
12:00
|
Proffered Papers |
| |
|
| |
|
|
12:30
|
Lunch |
| |
|
|
14:00
|
Session III :
Stratification of Tumors, Chairs: Ingrid S. Gribbestad,
Ph.D. & Kirstie S. Opstad, Ph.D. |
| |
|
|
14:00
|
Stratifying
Disease & Assessing Novel Treatments Using Magnetic
Resonance
Martin O. Leach, Ph.D.
Institute of Cancer Research
Surrey, England, UK |
| |
|
|
14:30
|
Combining
Metabolomics & Transcriptomics Using A New Harvesting
Method For High Quality Prostate Cancer Tissue Samples
May-Britt Tessem, Ph.D.
Norwegian University of Science and Technology
Trondheim, Norway |
| |
|
|
14:45
|
Proffered Papers |
| |
|
|
15:15
|
MRSI
of the Prostate: Current Value & New Potential for
Prostate Cancer Management
Tom W.J. Scheenen, Ph.D.
Radboud University, Nijmegen Medical Centre
Nijmegen, The Netherlands |
| |
|
|
15:30
|
Coffee Break |
| |
|
|
16:00
|
Session IV: MR
in Clinical Routine Assessment Of Cancer Treatment, Chair:
Michael V. Knopp, Ph.D. |
|
16:00
|
New
Developments in Clinical Imaging of Cancer
- permission
withheld
Heinz-Peter W. Schlemmer, M.D., Ph.D.
German Cancer Research Centre (DKFZ)
Heidelberg, Germany |
|
|
|
|
16:30
|
Amide Proton
Transfer (APT) Imaging of Pelvic Cancers
Guang Jia, Ph.D.
Ohio State University
Columbus, OH, USA |
|
|
|
|
16:45
|
Proffered Papers |
| |
|
| |
|
|
17:30
|
Free Time |
| |
|
|
19:00
|
Dinner |
| |
|
| |
Tuesday, 21 September |
| |
|
|
07:00-17:30 |
Registration |
|
07:30-08:30 |
Breakfast |
| |
|
|
08:30
|
«
William G.
Negendank Memorial Lecture:
Targeting the
Hallmarks of Cancer «
Robert J. Gillies, Ph.D.
H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL, USA |
| |
|
|
09:15
|
Coffee |
| |
|
|
09:30
|
Session V: MR
& New Approaches For Cancer Treatments, Chairs: Ross J.
Maxwell, Ph.D., & Tom Scheenen, Ph.D. |
| |
|
|
09:30 |
Rethinking
MRI Data Acquisition Approaches & Contrasts
Michael Garwood, Ph.D.
University of Minnesota
Minneapolis, MN, USA |
| |
|
|
09:55
|
Using the
Design of Nature's Own Nanoparticles as a Template to Create
Multifunctional Imaging Probes
Willem M. Mulder, Ph.D.
Mount Sinai School of Medicine
New York, NY, USA |
| |
|
|
10:20
|
Proffered
Papers |
| |
|
| |
|
|
11:05 |
Poster Session |
| |
|
|
13:00 |
Lunch |
| |
|
|
14:15 |
Session VI:
Newly Emerging Cancer MR Biomarkers, Chairs: E. Jim
Delikatny, Ph.D. & May-Britt Tessem, Ph.D. |
| |
|
|
14:15 |
Involvement of Human Choline Kinase Alpha
& Beta In Carcinogenesis: A Differential Role In Lipid Metabolism
& Biological Functions
- permission
withheld
Juan Carlos Lacal, Ph.D.
Instituto de Investigaciones Biomédica
Madrid, Spain |
| |
|
|
14:45 |
What Can 1H
MRS Tell Us About Tumor Biology - Potential Biomarkers In Gliomas?
Kirstie S. Opstad, Ph.D.
St. George Hospital
London, England, UK |
| |
|
|
15:15 |
Proffered
Papers |
| |
|
| |
|
|
16:00 |
Coffee |
| |
|
|
16:30 |
Session VII:
Working Group Sessions
The aim with the Working Group Sessions is to organize “in
depth” discussion groups to talk about and share experience
within selected topics. The working groups will be chaired
by experienced scientists in the particular field. |
| |
Working group
1 – Quantification of Contrast Uptake Discussion on
Compartment Modelling Methods, Arterial Input Function, &
Quantification vs. Empirical Analysis
Chair: Alan Jackson, Ph.D.
Discussion on compartment modelling methods, arterial input
function, quantification vs. empirical analysis |
| |
Working group
2 – Design of Animal Protocols Practical Considerations in
Experimental Design, Imaging Sequences,
Coils & Animal Beds
Chair: Arend Heerschap, Ph.D.
Practical considerations in experimental design, imaging
sequences, coils and animal beds |
| |
Working group
3 – Quantification of MRS: How to Perform Quantitative MRS
Experiments, Different Methods for Quantitative Analysis &
Quantification vs. Semiquantitative Data Assessment
Chair: John Kurhanewicz, Ph.D.
How to perform quantitative MRS experiments, different
methods for quantitative analysis, quantification vs.
semi-quantitative data assessment |
| |
Working group
4 – MR Diffusion for Treatment Response Choice of Sequences,
B-Values, Standardisation of Protocols, & Data Analysis
Chair: Harish Poptani, Ph.D.
Choice of sequences, b-values, standardisation of protocols,
data analysis |
| |
Working group
5 – Advanced MRS Challenges with High-Field MRS, Concepts
for Fast MRSI & Importance of Coil Design
Chairs: Patrick J. Bolan, Ph.D. & Tom W.J. Scheenen,
Ph.D.
Challenges with high-field MRS, concepts for fast MRSI,
importance of coil design |
| |
|
|
17:30
|
Free time |
| |
|
|
19:00-23:00
|
Dinner |
| |
|
| |
Wednesday, 22 September |
| |
|
|
07:30-12:00 |
Registration |
|
07:30-08:30 |
Breakfast |
| |
|
|
08:30
|
Session VIII:
Multimodal Imaging For Improved Cancer Treatment, Chairs:
Kyrre Emblem, Ph.D. & Susan M. Noworolski, Ph.D. |
| |
|
|
08:30 |
MRI in the
Development of Antiangiogenic & Vascular Targeting Agents
Alan Jackson, Ph.D.
University of Manchester
Manchester, England, UK |
| |
|
|
09:00
|
Multi-Modal
Imaging of Cancer Cachexia
Marie-France Penet, Ph.D.
Johns Hopkins School of Medicine
Baltimore, MD, USA |
| |
|
|
09:15
|
Proffered
Papers |
| |
|
| |
|
|
10:00
|
Coffee Break |
| |
|
|
10:30-12:00
|
Session IX: How
To Present MR Information To Clinicians, Chairs: Franklyn A.
Howe, D.Phil. & Savannah C. Partridge, Ph.D. |
| |
|
|
10:30
|
Clinical MRI:
How Do We Move Beyond the Visual Interpretation? -
Strategies & Challenges
Michael V. Knopp, M.D., Ph.D.
Ohio State University
Columbus, OH, USA |
| |
|
|
11:00
|
A Pattern
Recognition Approach For The Differentiation Of Brain Tumors
Based On MRI & MRSI
Jan Luts, Ph.D.
Katholieke Universiteit Leuven
Leuven, Belgium |
| |
|
|
11:15
|
Proffered
Papers |
| |
|
|
11:45
|
Dynamic Contrast Enhanced (DCE) & Diffusion Weighted
MRI in Monitoring Treatment Response of Head & Neck
Cancer
Harish Poptani, Ph.D.
University of Pennsylvania
Philadelphia, PA, USA |
| |
|
|
12:00 |
Adjourn/Lunch/Departures |
| |
|
|
|
The International Society for Magnetic Resonance in Medicine
is accredited by
the Accreditation Council for Continuing Medical Education
to
provide continuing medical education for physicians. |
|
|
|